[Efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir combined with ribavirin in Asian adult patients with chronic HCV genotype 1b infection and compensated cirrhosis].
Wei L, Wang GQ, Sarah J, Cheng Q, Xie MR, Wang M, Xu ZP, Duan JL, Hou MX, Zhang YX, Zhang G, Tang W, Zhao SM, Lin ZS, Jia JJ, Niu ZL, Gao H, Yuan MH, Lin XM, Zhou JD, Luo Y, Linda F, Niloufar M, Wang Y, Jia J.
Wei L, et al.
Zhonghua Gan Zang Bing Za Zhi. 2018 May 20;26(5):353-358. doi: 10.3760/cma.j.issn.1007-3418.2018.05.008.
Zhonghua Gan Zang Bing Za Zhi. 2018.
PMID: 29996203
Chinese.